• Chris McLellan

E45: How is AI accelerating the science behind pharmaceutical research?

Updated: Jun 14

We checked-in with Liran Belenzon, co-founder & CEO of BenchSci, the AI-assisted application that's accelerating science at 16 of the top 20 pharmaceutical companies and over 4,500 research centers worldwide


Click here to subscribe to our podcast and newsletter. Our special thanks to Microsoft Canada and Cinchy, the Dataware platform for sponsoring the 4th series of the Ask AI podcast.

Liran Belenzon is the CEO and co-founder of BenchSci. Born in Israel where he earned his law degree and sold his first startup, he immigrated to Canada to do his MBA where he met three Ph.D. students who were working on an AI platform that could solve the declining productivity of drug discovery caused by avoidable inefficiencies in preclinical research.


Together, they founded BenchSci in 2015.


About BenchSci


BenchSci’s vision is to bring novel medicine to patients 50% faster by 2025. They’re achieving it by empowering scientists with the world’s most advanced biomedical artificial intelligence.


Their AI-Assisted 'Reagent Selection' application decodes experimental text and images to present relevant figures and insights—enabling scientists to reduce time and uncertainty during the reagent and model system selection process.


Tune in to this Ask AI team check-in as host Carolyne Pelletier meets Liran Belenzon, co-founder & CEO of BenchSci, to ask the question:


How is AI accelerating the science behind pharmaceutical research?


Download podcast

Support episode

Like, share, or leave a comment on our social posts for this episode! 😍

Talk to our bot


This episode and hundreds of AI resources are available from the Ask AI chatbot.


Big thanks go out to our chatbot partner Ada for providing this World-class made-in-Canada technology!


Episode links

You might also like


How is AI helping to create a stethoscope for the 21st century?

The Ask AI interview with Dr. Jacob Jaremko, Associate Professor at the University of Alberta, Canada CIFAR AI Chair, and Co-founder, Medo.ai


How is AI being used to help predict breast cancer?

The Ask AI interview with Dr. Samuel Aparicio, Chair in Breast Cancer Research at UBC and Head of the BC Cancer Research Institute Department of Breast and Molecular Oncology.


How AI is advancing bedside wound treatment (and reducing patient exposure to COVID-19)?

The Ask AI interview with Justin Allport, Chief Engineer and Co-Founder at Swift Medical.


About Ask AI

Ask AI is a volunteer project exploring Canada's fast-emerging artificial intelligence sector. Our projects include thought leader interviews, team check-ins, and live events. To learn more about sponsorships, guest blogs, and volunteering, please contact us or ask our chatbot.

236 views1 comment